Inhalation

INH1026

Issue link: https://www.e-digitaleditions.com/i/1546950

Contents of this Issue

Navigation

Page 12 of 43

Inhalation OctOber 2026 11 this airflow is strongly shaped by the inhaler's unique internal architecture, replicating the device-specific flow patterns near the mouthpiece was an essen- tial initial step. For this purpose, the internal air- spaces of the four inhalers were reconstructed using computer- aided design (CAD) software, based on high- resolution surface data obtained with a 3D scanner (eviXscan 3D Heavy Duty Optima, Eva- tronix, Bielsko- Biała, Poland). As an example, Fig- ure 1 depicts the reconstructed 3D geometry of the near-mouthpiece region in the case of the Ellipta DPI. e airflow field in the reconstructed geome- tries was simulated by the use of ANSYS FLUENT CFD (computational fluid dynamics) code (version 2025 R1) (Canonsburg, Pennsylvania, US). A more detailed description of the numerical schemes can be found in reference [10]. To represent the wide variability in patient breathing patterns, simula- tions were performed at flow rates of 30, 45, 60 and 90 L/min. e resulting airflow profile at the inhaler exit was then applied as the inlet boundary condi- tion for the add-on or for the upper airways (mouth opening). e upper airways were modeled as the hydraulic equivalent of a physical mouth- pharynx- larynx replica [11]. For the simulation of air and particle transport, an Euler-Lagrange modeling approach was employed, wherein the air was treated as a continuous phase while the drug particles were modeled as discrete entities. eir size distributions were derived from accounting for usability, practicality and ergonomic considerations. From a fluid and particle dynamics perspective, several competing effects had to be bal- anced, making the selection of add-on shapes and dimensions an optimization problem. For example, although a conically diverging geometry can decel- erate the airflow, an excessively large cone angle may induce recirculation zones near the walls, leading to increased drug deposition on the add-on surfaces [7]. Conversely, a narrow cone angle requires a longer add-on with a greater surface area, which can like- wise elevate particle deposition. erefore, param- eters such as the cone angle and length required careful optimization. Internal partitions within the add-on can further help guide and stabilize the airflow, but they also intro- duce additional surfaces that may capture particles. For this reason, a wide range of initial add-on geom- etries—varying in form, size and number of internal divisions—were explored and subsequently refined using computational fluid and particle dynamics (CFPD) simulations. e final set of designs was then validated through both CFPD analyses and experimental measurements. Numerical simulations To design add-ons capable of influencing drug- particle trajectories in a controlled manner, it was first necessary to characterize the realistic airflow emerging from each inhaler's mouthpiece. Because Figure 1 A digitally reconstructed replica of the near-mouthpiece part of the Ellipta ® DPI (upper middle item) and the direction of airflow inside it (lower left). The lower right image shows the inner space (negative) of the reconstructed key piece, used in the CFPD simulations.

Articles in this issue

view archives of Inhalation - INH1026